Clinical Trials Directory

Trials / Completed

CompletedNCT05496439

Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction

Status
Completed
Phase
Study type
Observational
Enrollment
172 (actual)
Sponsor
Chongqing Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Study of the prognosis of patients with heart failure with preserved ejection fraction

Detailed description

Obesity is an independent risk factor for heart failure with preserved ejection fraction (HFpEF), however, the impact of visceral fat area (VFA) in patients with HFpEF is unclear. According to established process of patients' selection, a total of 172 patients whose mean age was 72 years were included in this study, and the median follow-up duration was 395.5 days(interquartile range: 207.5 to 535.5 days). All patients were divided into two groups based on the best cut-off value of VFA, and the primary outcome of this study was all-cause death in patients with HFpEF. The aim of this study was to clarify whether VFA has prognostic value in patients with HFpEF by Kaplan-Meier analysis and cox analysis.

Conditions

Timeline

Start date
2020-03-01
Primary completion
2022-05-22
Completion
2022-07-06
First posted
2022-08-11
Last updated
2022-08-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05496439. Inclusion in this directory is not an endorsement.

Study of the Prognosis of Patients With Heart Failure With Preserved Ejection Fraction (NCT05496439) · Clinical Trials Directory